The Road to Successful Lymphoma Treatment: Where We Are Headed


At the 2017 ASCO meeting in Chicago, Host Andrew Schorr catches up with expert Dr. Stephen Ansell, leader of the Lymphoma Group at Mayo Clinic in Rochester, Minnesota, to discuss updates for those living with Lymphoma. Dr. Ansell elaborates on updates for two clinical trials, named the Bright Trial and the Still Trial, for those with low grade, indolent, or follicular type lymphomas. He also discusses effective oral medication therapies that are approved. Dr. Ansell says, "what I think is very important is to be able to balance effective therapy with the least toxicity possible." 

Sign in or Register to view comments.